出处
《中国实用医药》
2008年第30期201-203,共3页
China Practical Medicine
基金
绵阳市科委资助课题(项目编号:06S042-7)
参考文献15
-
1[1]Engwegen J.Y,Gast M.C,Schellens J.H,et al.Clinical proteomics:searching for better tumour markers with SELDITOFmass spectrometry.Trends Pharmacol.Sci,2006,27:251-259.
-
2[2]Petricoin E.F,Ornstein D.K,Liotta L.A.Clinical proteomics:Applications for prostate cancer biomarker discovery and detection.Urol.Oncol,2004,22:322-328.
-
3[3]Banks R.E,Dunn M.J,Hochstrasser D.F,et al.Proteomics:new perspectives,new biomedical opportunities.Lancet,2000,356:1749-1756.
-
4[4]Stein L.D.Human genome:end of the beginning.Nature,2004,431,:915-916.
-
5[5]Schnitt S.J.Traditional and newer pathologic factors.J.Natl.Cancer Inst.Monogr,2001,30:22-26.
-
6[6]Donegan W.L.Tumor-related prognostic factors for breast cancer.CA Cancer J.Clin,1997,47:28-51.
-
7[7]Alaiya A,Al-Mohanna M,Linder S.Clinical cancer proteomics:promises and pitfalls.J.Proteome Res,2005,4:1213-1222.
-
8[8]Ariazi EA,Ariazi JL,Cordera F,et al..Estrogen receptors as therapeutic targets in breast cancer.Curr.Top.Med Chem,2006,6:195-216.
-
9[9]Cai Z,Chiu J.F,He Q.Y.Application of proteomics in the study of tumor metastasis.Genomics Proteomics Bioinformatics,2004,2:152-166.
-
10[10]Hoehn G.T,Suffredini A.F.Proteomics.Crit.Care Med,2005,33(suppl.):444-448.
同被引文献20
-
1Wu G,Guo Z,Chang X,et al .LOXL1 and LOXL4 are epigeneticaUy silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer[J].Cancer Res,2007,67(9):4123-4129.
-
2Li W, Liu G,Chou IN,et al.Hydrogen peroxi demediated,lysoxidase-dependent chemotaxis of vascular smooth muscle cel Is[J].J CellBi Chem,2000,78(4):550-557.
-
3Sebban S,Golan-Gerstl R,Karni R. Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer[J]. Clin Exp Metastasis,2013,30(1):103-117.
-
4Kim MS,Kim SS,Jung ST, et al.Expression and purification of enzymatically active forms of the human lysyl oxidase-like protein 4[J].J Biol Chem,2003,278(52):52071-52074.
-
5Siddikuzzaman,Grace VM, Guruvayoorappan C. Lysyloxidase:a poteitial target for cancer therapy[J]. Inflammopharmacology,2011,19(3): 117-129.
-
6Lin CY, Anders J, Johnson M,et al.Molecular cloning of cDNA for matriptase,a matrix-degrading serine protease with trypsin-like activity[J].J Biol Chem,1999,274(26):18231-18236.
-
7List K,Bugge TH,Szabo R. Matriptase:potent proteolysis on the cell surface[J].Mol Med,2006,12(1/3):1-7.
-
8Lee JW,Yong Song S,Choi JJ,etal.Increased expression of matriptase is associated with histopathologic grades ofcervicalneoplasia[J].Hum Pathol,2005,36(6):626-633.
-
9Uhland K.Matriptase and its putative role in cancer[J].Cell Mol Life Sci,2006,63(24):2968-2978.
-
10Ye J,Kawaguchi M,Haruyama Y, et al.Loss of HAI-1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model[J].Cancer Sci,2013,Oct 22. doi:10.1111/cas.12306.
引证文献2
-
1王秀萍,于祥远,陈美玲,董滨华,毛晓丹,林芬,孙蓬明.赖氨酰氧化酶样-4与丝氨酸蛋白酶基因在人宫颈癌细胞中的表达[J].中国医药指南,2014,12(10):4-5. 被引量：1
-
2于祥远,王秀萍,董滨华,毛晓丹,林芬,孙蓬明.赖氨酰氧化酶样-4与尿激酶型纤溶酶原激活物及其受体在人宫颈癌细胞中的表达及意义[J].福建医药杂志,2014,36(3):1-4. 被引量：2
-
1康梅子,戴兵.慢性肾衰竭对成纤维细胞生长因子23表达调控的影响[J].肾脏病与透析肾移植杂志,2016,25(4):371-374. 被引量：8
-
2徐妍力,滕银成.蛋白质组学在卵巢癌肿瘤标志物研究中的应用与进展[J].中国妇幼保健,2011,26(34):5463-5465.
-
3柴丽丽,郑长黎.功能蛋白质组学在胃癌研究中的应用进展[J].国际病理科学与临床杂志,2005,25(6):498-500. 被引量：1
-
4John A Habeshaw,郑珊珊.AIDS的致病机制:HIV外壳及其与细胞蛋白质的相互作用[J].国外医学（免疫学分册）,1991,14(4):207-210.
-
5范艳兰,李小秋.应用利妥昔单抗治疗弥漫性大B细胞淋巴瘤预后相关标志物的再评估[J].中国癌症杂志,2013,23(6):467-471. 被引量：1
-
6陈敏,冯文莉,黄宗干.化疗药物诱导急性白血病细胞凋亡及机制[J].国外医学（输血及血液学分册）,2001,24(5):406-408.
-
7孔令根,陈焕辉,何丽娟.干扰素对肺腺癌PC84045细胞蛋白质合成作用的影响[J].广州医药,1993,24(5):2-3.
-
8肿瘤疫苗[J].中国药理学通报,2005,21(3):309-309.
-
9孙文东,刘秀怀,邓国仁.胃癌和癌旁组织癌基因c-Ha-ras第12位密码点突变测定的研究[J].生物化学杂志,1990,6(6):563-565.
-
10孙文东,邓国仁.胃癌和癌旁组织癌基因c—Ha—ras第12位密码点突变测定的研究[J].石河子医学院学报,1990,12(1):1-4.
